$Gilead Sciences(GILD.US) rose over five percentage points, leading the gains among this batch of large pharmaceutical companies; $Eli Lilly(LLY.US) and $Unitedhealth(UNH.US) rose two to three points, while $Merck(MRK.US) saw a slight increase. On the day when AI stocks in the tech sector were selling off, money fled to safe havens with strong certainty like large-cap pharma stocks — $Eli Lilly(LLY.US) has the long-term logic of weight-loss drugs and oncology pipelines, and $Unitedhealth(UNH.US) is stabilized by cash flow from the Medicare side. On days like this, the stability of big pharma is more valuable than anything else 😎
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
